AlgoTherapeutix

Suresnes, France

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

$21.5M raised

Mar 2023

Series B

Biotechnology Information Technology Pharmaceutical

Top Investors

BpifranceOmnes CapitalTurenne CapitalUI InvestissementInnoBio Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AlgoTherapeutix

How much funding has AlgoTherapeutix raised?

AlgoTherapeutix has raised $21.5M in total funding. The most recent round was Series B. The last funding was announced in March 2023.

Who are AlgoTherapeutix's investors?

AlgoTherapeutix's investors include Bpifrance, Omnes Capital, Turenne Capital, UI Investissement, InnoBio Fund.

Where is AlgoTherapeutix headquartered?

AlgoTherapeutix is headquartered in Suresnes, France.

What does AlgoTherapeutix do?

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

What stage is AlgoTherapeutix at?

AlgoTherapeutix is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 14, 2023.

MLA

"AlgoTherapeutix — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/algotherapeutix. Accessed June 7, 2026.

APA

VCBacked. (2023). AlgoTherapeutix — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/algotherapeutix

Wikipedia (cite web)

{{cite web |title=AlgoTherapeutix — Funding & Investors |url=https://www.vcbacked.co/company/algotherapeutix |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 14, 2023.

Similar Companies in Biotechnology